Table 2 MRM transitions of vitamin D analogues and internal standard
Compounds | Precursor | Product | CE |
|---|---|---|---|
Vitamin D3 | 385.3 | 159.2 | 40 |
Vitamin D2 | 397.4 | 159.2 | 43 |
25OHD3 | 401.3 | 383.1 | 41 |
401.3 | 365.1 | 41 | |
401.3 | 159.2 | 45 | |
25OHD2 | 413.3 | 377.2 | 51 |
413.3 | 355.5 | 51 | |
413.3 | 383.1 | 35 | |
1α25(OH)2 D3 | 399.1 | 135.1 | 61 |
399.1 | 381.1 | 41 | |
1α25(OH)2 D2 | 411.5 | 151.1 | 55 |
3-epi-25OHD3 | 401.3 | 383.1 | 41 |
401.3 | 365.1 | 41 | |
401.3 | 159.2 | 45 | |
3-epi-25OHD2 | 413.3 | 377.2 | 51 |
413.3 | 355.5 | 51 | |
413.3 | 383.1 | 35 | |
7αC4 | 401.3 | 383.1 | 41 |
401.3 | 365.1 | 41 | |
401.3 | 159.2 | 45 | |
Stanozolol-D3 | 332.2 | 81.2 | 45 |